Puma Biotechnology IncLatest Puma Biotechnology Inc News and UpdatesCompany & Industry OverviewsPerjeta Could Significantly Boost Roche’s Revenue Growth in 2018In December 2017, the Food and Drug Administration approved Roche’s (RHHBY) Perjeta based on the results of its phase three Aphinity trial.
Company & Industry OverviewsPerjeta Could Significantly Boost Roche’s Revenue Growth in 2018In December 2017, the Food and Drug Administration approved Roche’s (RHHBY) Perjeta based on the results of its phase three Aphinity trial.
